Jane Street Group LLC Sells 52,614 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)

Jane Street Group LLC lessened its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 56.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,259 shares of the company’s stock after selling 52,614 shares during the quarter. Jane Street Group LLC owned about 0.09% of KORU Medical Systems worth $113,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in KRMD. Meros Investment Management LP grew its position in shares of KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after acquiring an additional 137,918 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of KORU Medical Systems during the 2nd quarter valued at approximately $107,000. Finally, Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of KORU Medical Systems by 77.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after purchasing an additional 26,860 shares during the last quarter. 58.60% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Piper Sandler lifted their target price on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a report on Thursday, November 14th. Craig Hallum upped their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Canaccord Genuity Group upped their target price on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Finally, Lake Street Capital boosted their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a report on Tuesday. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $4.30.

KORU Medical Systems Stock Performance

KRMD stock opened at $4.07 on Wednesday. The company has a market cap of $186.56 million, a P/E ratio of -16.28 and a beta of 0.45. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37. The stock’s fifty day moving average price is $3.75 and its 200-day moving average price is $2.95. KORU Medical Systems, Inc. has a 1 year low of $1.98 and a 1 year high of $4.60.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.